Type to search

Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies | PTF
Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform | Pharmtech Focus